Loading company…
Established in 2007 and based in Taipei, Taiwan, TaiMed Biologics Inc. develops biotherapeutics and offers CDMO services.
TaiMed Biologics Inc., established in 2007 and headquartered in Taipei, operates as a biologics developer focused on the clinical development of biotherapeutics, with a branch in Hsinchu and a subsidiary in the USA. In March 2010 it raised USD 22 million in Series B financing from YFY Biotech Management Company. In March 2018 its product TMB-355 was approved by the US FDA as a new protein drug.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in